The Antipsychotic Drug Sertindole is A Specific Inhibitor of Alpha(1a)-Adrenoceptors in Rat Mesenteric Small Arteries

M Ipsen,YY Zhang,N Dragsted,CD Han,MJ Mulvany
DOI: https://doi.org/10.1016/s0014-2999(97)01242-9
IF: 5.195
1997-01-01
European Journal of Pharmacology
Abstract:We have investigated the adrenergic antagonist effect of the antipsychotic sertindole in rat resistance vessels and in membranes of HEK293 cells transfected with α1-adrenoceptors. Segments of rat mesenteric small arteries or rat aorta were mounted on a myograph for isometric tension recording. In mesenteric small arteries, specific α1A-adrenoceptor antagonists (5-methyl urapidil and WB-4101 (2-(2,6-dimethoxyphenoxyethyl) aminomethyl-1,4-benzodioxane)) inhibited phenylephrine responses with high affinity (pA2=9.1 and 9.5, respectively). Chlorethylclonidine (α1B- and α1D-adrenoceptor antagonist) and BMY7378 (8-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-8-azaspiro [4,5] decane-7,9-dione dihydrochloride, α1D-adrenoceptor antagonist) had little effect. This indicated that the adrenoceptor subtype in the mesenteric small arteries was of the α1A subtype. Sertindole inhibited the phenylephrine response of mesenteric small arteries (pA2=9.0), but had little effect on the phenylephrine response of aorta (which lacks α1A-adrenoceptors). The specific action of sertindole on α1A-adrenoceptors was supported by experiments with membranes of HEK293 (human embryonic kidney) cells transfected with the α1A-, α1B- and α1D-adrenoceptors. Here, with concurrent incubation, sertindole showed selective competitive inhibition of BE2254 (2-β(4-hydroxyphenyl)-ethylaminomethyl)-tetralone) binding to α1A-adrenoceptors (Ki=8.9), compared to α1B-adrenoceptors (Ki=7.1) and α1D-adrenoceptors (Ki=6.8). Despite the apparent competitive action sertindole, it was not possible to wash out its antagonist effect within 6 h in the functional phenylephrine concentration–response experiments. Furthermore, in the membranes of HEK293 cells transfected with the α1A-adrenoceptors, binding of 125I-BE2254 was reduced by 45% following preincubation with sertindole (1 nM). We conclude that the α-adrenoceptors of rat mesenteric small arteries are of the α1A-type, and that sertindole is a specific pseudo-irreversible competitive antagonist of this adrenoceptor sub-type.
What problem does this paper attempt to address?